CareCloud Completes Full Redemption of Series B Preferred Stock, Capping a Decade of Transformational Growth and Profitability
CareCloud (Nasdaq: CCLD) fully redeemed 100% of its 8.75% Series B Preferred Stock, funded by a new $50 million credit facility led by Citizens Bank with Provident Bank participation.
Rhea-AI Summary
CareCloud (Nasdaq: CCLD) fully redeemed 100% of its 8.75% Series B Preferred Stock, funded by a new $50 million credit facility led by Citizens Bank with Provident Bank participation. The move replaces higher-cost preferred equity with lower-cost debt and simplifies the capital structure.
Since 2015, revenue grew from about $23 million to approximately $130 million expected in 2026, with over 20 acquisitions, more than 45,000 providers served, first full year of positive GAAP net income in 2025, and about $30 million expected 2026 annualized adjusted EBITDA.
CareCloud also maintains a $60 million ATM equity facility and plans to issue shares only at or above $5.00 per share.
Positive
- Full redemption of 100% of 8.75% Series B Preferred Stock
- $50 million credit facility replaces higher-cost preferred equity
- Revenue growth from ~$23 million to ~$130 million expected in 2026
- More than 20 acquisitions and over 45,000 providers served
- First full year of positive GAAP net income achieved in 2025
- Approximately $30 million annualized adjusted EBITDA expected in 2026
- $60 million ATM facility provides flexible access to growth capital
Negative
- $50 million credit facility increases reliance on debt financing
- ATM equity facility could dilute shareholders if shares are issued
Details
News Market Reaction – CCLD
In the May 18 session, CCLD gained 0.47%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- ATM facility size
- $60 million
- Existing At-The-Market equity facility with Citizens Bank
- Credit facility
- $50 million
- Recently secured facility used to fund Series B redemption
- Minimum ATM price
- $5.00 per share
- Management intends to tap ATM only at or above this level
- Series B coupon
- 8.75%
- Dividend rate on redeemed Series B Preferred Stock
- Revenue 2015
- $23 million (approx.)
- Revenue level when first preferred shares were issued in 2015
- Expected 2026 revenue
- $130 million (approx.)
- Management’s 2026 revenue expectation referenced in release
- Expected 2026 EBITDA
- $30 million (approx.)
- Annualized adjusted EBITDA expected during 2026
- Healthcare providers served
- More than 45,000
- Scale of CareCloud’s customer base
Historical Context
-
Announced Nasdaq Analyst Day and highlighted $50M facility and prefunded redemption.
-
Reported revenue growth, GAAP net income, and reaffirmed 2026 guidance with AI launches.
-
Set date and access details for upcoming Q1 2026 earnings release and call.
-
Reaffirmed financial guidance after capital structure simplification and preferred redemption plan.
-
Closed $50M credit facility and scheduled full redemption of Series B preferred stock.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
Series B Preferred Stock financial
credit facility financial
At-The-Market ("ATM") equity facility financial
GAAP net income financial
adjusted EBITDA financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company intends to access growth capital opportunistically only at or above
SOMERSET, N.J., May 18, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD), (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced the full redemption of
The redemption was funded through CareCloud’s recently secured
“This is a defining moment for CareCloud,” said Stephen Snyder, Chief Executive Officer of CareCloud. “Over the past decade, preferred equity helped fuel our transformation from a traditional medical billing company into a scaled, profitable, AI-enabled healthcare technology platform. Today, we are emerging with a cleaner capital structure, stronger cash flow, and a clear path toward long-term shareholder value creation.”
Since issuing its first preferred shares in 2015, CareCloud has:
- Grown revenue from approximately
$23 million to approximately$130 million expected in 2026. - Completed more than 20 acquisitions;
- Expanded to serve more than 45,000 healthcare providers; and
- Achieved its first full year of positive GAAP net income in 2025.
These results reflect a high-quality, recurring-revenue platform with approximately
CareCloud also announced that it maintains a
“With the full redemption of our Series B Preferred Stock now complete and our capital structure significantly simplified, CareCloud is entering its next chapter as a profitable, cash-generative healthcare technology company,” added Snyder. “We believe we are exceptionally well-positioned to accelerate growth, expand margins through AI and automation, and continue building long-term value for our shareholders.”
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. The Company’s suite of AI and technology-enabled solutions helps healthcare organizations increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 45,000 providers rely on CareCloud’s solutions and services across revenue cycle management, practice management, electronic health records, patient experience management, business intelligence and digital health.
Follow CareCloud on LinkedIn, X and Facebook.
For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding future growth, profitability, acquisition opportunities, use of the ATM facility, AI initiatives, and future shareholder value creation. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Please refer to the Company’s filings with the Securities and Exchange Commission for additional information regarding these risks and uncertainties.
SOURCE: CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.